The Global Ophthalmic Drug Market was valued at USD 38.47 billion in 2024 and is expected to reach USD 87.37 billion by 2034, growing at a CAGR of 8.6%. Ophthalmic drugs encompass therapies for glaucoma, dry eye, infections, retinal disorders, and post-surgical care. Rising prevalence of eye diseases, coupled with increasing awareness and advanced drug delivery systems, is driving...